Novo Nordisk A/SEquity-NMS: NVO
Equity-NMS: NVO
$119.74
-1.80
(29 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$119.74
Open
$119.74
Today’s high
$120.28
Today’s low
$118.91
52W low
$67.66
52W high
$124.87
1Y
71.14%
5Y
39.13%
Div yield
0.84%
Dividend
1.03
Shares O/S
3.44B
Market cap
411.32B
Insights
NVO has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
NVO price is above its 200 day moving average
NVO is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.

The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations. .


FAQs

Can I buy Novo Nordisk A/S shares in India?
How to buy Novo Nordisk A/S shares in India?
What is the share price of Novo Nordisk A/S?
What is the Market Capitalization of Novo Nordisk A/S?
What is the PE ratio of Novo Nordisk A/S?
Is Novo Nordisk A/S a good stock to buy?
In which sector / industry does Novo Nordisk A/S operate?